You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Abivax
since
auto-detected in 3 stories
8 days ago
Shares of French biotech Abivax tumbled 32% after it reported fresh data on its lead asset.
78 days ago
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC ⊕
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
5 months ago
Europe's best-performing stock is up 1,400% this year. Here's what next ⊖
Abivax stock has far outperformed the broader index with a stellar performance, even as the company is making big financial losses.
page 1 of 1